Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Current Assets: 2009-2025

Historic Current Assets for BIO-TECHNE (TECH) over the last 17 years, with Jun 2025 value amounting to $608.3 million.

  • BIO-TECHNE's Current Assets fell 6.02% to $609.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $609.5 million, marking a year-over-year decrease of 6.02%. This contributed to the annual value of $608.3 million for FY2025, which is 1.48% down from last year.
  • As of FY2025, BIO-TECHNE's Current Assets stood at $608.3 million, which was down 1.48% from $617.4 million recorded in FY2024.
  • BIO-TECHNE's 5-year Current Assets high stood at $621.5 million for FY2023, and its period low was $510.6 million during FY2021.
  • Over the past 3 years, BIO-TECHNE's median Current Assets value was $617.4 million (recorded in 2024), while the average stood at $615.7 million.
  • Per our database at Business Quant, BIO-TECHNE's Current Assets declined by 1.98% in 2021 and then grew by 18.60% in 2022.
  • Yearly analysis of 5 years shows BIO-TECHNE's Current Assets stood at $510.6 million in 2021, then increased by 18.60% to $605.6 million in 2022, then grew by 2.63% to $621.5 million in 2023, then fell by 0.65% to $617.4 million in 2024, then declined by 1.48% to $608.3 million in 2025.